Pain Medicine, Interventional Pain Medicine · Dalton, GA
NPI
1528383965
Since 2010
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1413 Chattanooga Ave
Dalton, GA, 30720
Phone (706) 279-2635
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
2,495 services
Medicare patients, 2024
372
Average age 72
Drug cost, 2024
$296K
5,203 prescriptions
Company payments, 2025
$447
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kendrick W Thomas was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 658 times for 84 patients. In total Kendrick W Thomas billed 2,495 services in 50 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 658 | 84 | $0.08 | $55.7 |
| 99214 Office E&M - Established | Office | 561 | 277 | $78.22 | $44K |
| 80307 Drug Tests | Office | 323 | 224 | $58.41 | $19K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 133 | 107 | $192.18 | $26K |
| 99213 Office E&M - Established | Office | 124 | 107 | $41.43 | $5,137 |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 92 | 33 | $0.10 | $9.52 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 79 | 64 | $151.81 | $12K |
| 99204 Office E&M - New | Office | 60 | 60 | $105.82 | $6,349 |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 52 | 52 | $241.98 | $13K |
| 77002 Imaging - Miscellaneous | Office | 42 | 35 | $71.52 | $3,004 |
| 20610 Joint Injection | Office | 34 | 31 | $38.01 | $1,292 |
| 64494 Nerve Block Injection - Back | Office | 29 | 22 | $87.15 | $2,527 |
| 64493 Nerve Block Injection - Back | Office | 29 | 22 | $162.93 | $4,725 |
| 64483 Nerve Block Injection - Back | Office | 28 | 27 | $203.06 | $5,686 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 23 | 22 | $228.87 | $5,264 |
By year: 2022 $367K for 6,319 services; 2023 $339K for 4,392 services; 2024 $193K for 2,495 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 323 | 224 | $58.41 | $19K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 133 | 107 | $192.18 | $26K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 79 | 64 | $151.81 | $12K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 52 | 52 | $241.98 | $13K |
| 81223 Genetic Analysis | 16 | 16 | $489.02 | $7,824 |
| 81291 Genetic Analysis | 16 | 16 | $64.03 | $1,024 |
Medicare prescription drug claims, 2024
In 2024, the drug Kendrick W Thomas prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,313 prescriptions and refills. In total Kendrick W Thomas wrote 5,203 Medicare prescriptions that cost $296K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,313 | 1,313 | 480 | $43K |
| Gabapentin Generic | 511 | 527 | 289 | $4,967 |
| Tramadol Hcl Generic | 377 | 377 | 177 | $3,285 |
| Pregabalin Generic | 335 | 337 | 173 | $6,808 |
| Alprazolam Generic | 262 | 262 | 239 | $260 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 244 | 244 | 84 | $7,764 |
| Tizanidine Hcl Generic | 236 | 256 | 137 | $1,854 |
| Buprenorphine Generic | 198 | 198 | 98 | $41K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 195 | 195 | 114 | $2,970 |
| Oxycodone Hcl Generic | 161 | 161 | 52 | $2,912 |
| Lidocaine Generic | 158 | 173 | 89 | $17K |
| Baclofen Generic | 110 | 116 | 57 | $1,061 |
| Naloxone Hcl Generic | 107 | 111 | 106 | $5,887 |
| Cyclobenzaprine Hcl Generic | 80 | 84 | 43 | $703 |
| Diclofenac Sodium Generic | 78 | 84 | 51 | $8,034 |
Brand drugs: 257 claims; generic drugs: 4,946 claims; opioid claims: 2,771.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kendrick W Thomas $447 ($447 in general payments such as food, travel and fees) from 6 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $126.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.